DGII News | Roxom Stocks

1 BTC

- USD

Loading market data...

Mkt Cap

$2.65B

Volume

286.93K

Next Earnings

November 11th

Chart Financials Earnings News About Insider Filings

Digi International VP Trims His Stake — The Real Question Is Whether the IoT Shift has legsDavid Sampsell, VP of Corporate Development at Digi International, sold 6,375 shares worth approximately $415,000 on May 13, 2026, representing about 7% of his direct holdings. The sale follows an 84% one-year stock gain. Analysts view this as reasonable risk management rather than a conviction change, as Sampsell retains over 83,000 shares. The key question for investors is whether Digi's transition toward software subscriptions and cloud-based services will justify current valuations, with focus on whether software/services revenue growth and margin expansion materialize in upcoming quarterly results.The Motley Fool · Jun 11, 2026

Digital First Operations Infrastructure Spending Continues, Accelerating Across Every Major IndustryDigital transformation spending is accelerating across industries as businesses invest heavily in SEO, cloud services, managed IT support, and online infrastructure. The global managed services market is projected to grow from $401 billion in 2025 to $847 billion by 2033, while digital marketing is expected to expand from $11 billion to $18.5 billion by 2030. Several tech companies are positioning themselves to capitalize on this growth through strategic initiatives and new service offerings.Benzinga · May 19, 2026

Why Digi International Stock Crushed it With a 7% Gain TodayDigi International reported strong Q4 2025 financial results, beating analyst expectations with 9% year-over-year revenue growth and record annual recurring revenue of $152 million, leading to a 7% stock price increase.The Motley Fool · Nov 13, 2025

OSS Announces Third Order from Leading Asian Defense Contractor for Autonomous Maritime ApplicationOne Stop Systems (OSS) received a $340,000 purchase order from an Asian defense contractor for autonomous maritime systems, with anticipated cumulative sales of $4 million between 2026-2029 for unmanned surface vehicle production.GlobeNewswire Inc. · Jun 26, 2025

Trump's Tariff Storm: 3 Survival Strategies US Companies Are Using To Fight BackUS companies are using three main strategies to combat potential tariff hikes by the Trump administration: raising prices, stockpiling goods, and shifting supply chains away from China.Benzinga · Dec 10, 2024

WAGMI Announces Sponsors for the Biggest Blockchain Event in AmericaWAGMI, a blockchain conference in Miami, announced its initial list of sponsors for the event happening in January 2025. The conference is already 75% sold out, with over 10,000 attendees expected from over 100 countries.GlobeNewswire Inc. · Nov 19, 2024

Digi International (DGII) Q2 Earnings and Revenues Top EstimatesDigi International (DGII) delivered earnings and revenue surprises of 4.26% and 0.68%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · May 1, 2024

Assessing Digi Intl: Insights From 5 Financial AnalystsProviding a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Digi Intl (NASDAQ:DGII) in the last three months. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 1 2 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $37.8, with a high estimate of $45.00 and a low estimate of $30.00. Observing a downward trend, the current average is 19.01% lower than the prior average price target of $46.67. Understanding Analyst Ratings: A Comprehensive Breakdown The perception of Digi Intl by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Tommy Moll Stephens & Co. Raises Overweight $45.00 $40.00 Tommy Moll Stephens & Co. Maintains Overweight $40.00 - Josh Nichols B. Riley Securities Announces Buy $34.00 - Harsh Kumar Piper Sandler Lowers Overweight $30.00 $50.00 Tommy Moll Stephens & Co. Lowers Overweight $40.00 $50.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Digi Intl. This insight gives a snapshot of analysts' perspectives on ...Full story available on Benzinga.comBenzinga · Feb 5, 2024

Why Digi International Stock Jumped 16.2% TodayAn earnings beat and higher ARR got investors excited.The Motley Fool · Feb 1, 2024

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionShares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 billion versus estimates of $4.34 billion. C.H. Robinson Worldwide shares dipped 12.6% to $73.49 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers Minim, Inc. (NASDAQ: MINM) shares climbed 57.3% to $6.45. David E. Lazar recently disclosed a 51% active stake in Minim. Clearmind Medicine Inc. (NASDAQ: CMND) jumped 51% to $2.17. Clearmind Medicine announced long-term licensing agreement with BIRAD. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) climbed 52.9% to $5.00. NeuroBo Pharmaceuticals announced FDA clearance of IND for Phase 1 clinical trial of DA-1726 for the treatment of obesity. FibroBiologics, Inc. (NASDAQ: FBLG) shares climbed 47.4% to $42.90. FibroBiologics announced direct listing on the NASDAQ. Celularity Inc. (NASDAQ: CELU) rose 36% to $0.5191. Celularity said it sees FY24 net sales of $50 million to $56 million. Cimpress plc (NASDAQ: CMPR) jumped 28.8% to $96.90 after the company reported better-than-expected second-quarter financial results and said the board authorized the repurchase of up to $150 million of company shares. TuSimple Holdings Inc. (NASDAQ: TSP) rose 28% to $0.2950. Elevai Labs, Inc. (NASDAQ: ELAB) gained 23.5% to $0.84 after gaining 8% on Wednesday. Asset Entities Inc. (NASDAQ: ASST) climbed 22.8% to $0.5650. Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares jumped 20.4% to $0.6649. Kiora Pharmaceuticals announced a private placement of up to $45 million. Evaxion Biotech A/S (NASDAQ: EVAX) gained 19.5% to $4.70. Evaxion Biotech announced pricing of $15 million public offering of 3.750 million ADS at $4.00 per ADS. Nextracker Inc. (NASDAQ: NXT) rose climbed 18.8% to $53.79 after the company reported better-than-expected third-quarter financial results. SunPower Corporation (NASDAQ: SPWR) jumped 18.1% to $3.5791. BioRestorative Therapies, Inc. (NASDAQ: BRTX) gained 16.4% to $1.8850. Corteva, Inc. (NYSE:Benzinga · Feb 1, 2024

DGIIDigi International Inc

DGII

Pay with—

Start Trading

Available Balance0.00

Your PositionYou don't own any DGII yet.

Related Tickers

Earnings

Mkt Cap

$2.65B

Volume

286.93K

Next Earnings

November 11th